mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |